(Q31126318)

12 October 2017

1 reference

2 November 2019

Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model (English)

1 reference

12 October 2017

pulmonary tuberculosis

1 reference

Mycobacterium tuberculosis

2 November 2019

1 reference

2 November 2019

1 reference

inferred from abstract

1 reference

Robert S Wallis

1

1 reference

12 October 2017

Cunshan Wang

series ordinal

2

1 reference

12 October 2017

Daniel Meyer

series ordinal

3

1 reference

12 October 2017

Neal Thomas

series ordinal

4

1 reference

12 October 2017

language of work or name

English

0 references

publication date

5 August 2013

3 references

12 October 2017

23 March 2019

2 November 2019

3 references

12 October 2017

23 March 2019

2 November 2019

8

1 reference

12 October 2017

8

1 reference

12 October 2017

e71116

1 reference

Creative Commons Attribution

12 October 2017

2 references

23 March 2019

2 November 2019

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

The BUGS project: Evolution, critique and future directions

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Prediction of the Tuberculosis Reinfection Proportion from the Local Incidence

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Biomarkers for tuberculosis disease activity, cure, and relapse

14 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071116

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071116

Timing of relapse in short-course chemotherapy trials for tuberculosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733776

Sustainable tuberculosis drug development

25 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940699

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940699

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report

1 reference

https://pubmed.ncbi.nlm.nih.gov/23940699

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0071116

1 reference

12 October 2017

0 references

1 reference

12 October 2017

PubMed publication ID

23940699

1 reference